$AKYA
Akoya Biosciences, Inc. Stock $akya

$akya Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000155837024007998 Filed on May 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$23.16M	$18.35M
YoY Change	-1.52%	-14.29%
Cost Of Revenue	$9.778M	$9.971M
YoY Change	-14.27%	9.37%
Gross Profit	$13.39M	$8.379M
YoY Change	10.48%	-31.84%
Gross Profit Margin	57.79%	45.66%
Selling, General & Admin	$19.09M	$19.86M
YoY Change	-15.92%	-8.71%
% of Gross Profit	142.64%	237.06%
Research & Development	$5.288M	$5.554M
YoY Change	-15.7%	-3.79%
% of Gross Profit	39.5%	66.28%
Depreciation & Amortization	$1.926M	$2.051M
YoY Change	4.28%	-3.3%
% of Gross Profit	14.39%	24.48%
Operating Expenses	$24.47M	$29.96M
YoY Change	-21.97%	0.79%
Operating Profit	-$11.08M	-$21.59M
YoY Change	-42.4%	23.8%
Interest Expense	-$2.606M	-$2.612M
YoY Change	19.82%	27.17%
% of Operating Profit
Other Income/Expense, Net	-$80.00K	-$161.0K
YoY Change	-23.81%	235.42%
Pretax Income	-$13.10M	-$23.42M
YoY Change	-36.96%	24.76%
Income Tax	$47.00K	$63.00K
% Of Pretax Income
Net Earnings	-$13.15M	-$23.48M
YoY Change	-36.79%	24.9%
Net Earnings / Revenue	-56.76%	-127.98%
Basic Earnings Per Share	-$0.27	-$0.48
Diluted Earnings Per Share	-$0.27	-$0.48
COMMON SHARES
Basic Shares Outstanding	49.39M	49.14M
Diluted Shares Outstanding	49.42M	49.19M

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$45.22M	$61.58M
YoY Change	-51.54%	2.2%
Cash & Equivalents	$8.923M	$13.04M
Short-Term Investments	$36.30M	$48.54M
Other Short-Term Assets	$2.938M	$3.793M
YoY Change	-23.59%	-4.63%
Inventory	$24.80M	$22.99M
Prepaid Expenses
Receivables	$16.55M	$13.47M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$89.51M	$101.8M
YoY Change	-29.05%	11.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.164M	$8.964M
YoY Change	-26.71%	-14.01%
Goodwill	$18.26M	$18.26M
YoY Change	0.0%	0.0%
Intangibles	$15.99M	$16.70M
YoY Change	-16.41%	-14.35%
Long-Term Investments	$3.496M
YoY Change
Other Assets	$647.0K	$654.0K
YoY Change	-6.91%	-5.49%
Total Long-Term Assets	$54.23M	$52.92M
YoY Change	-13.52%	-15.49%
TOTAL ASSETS
Total Short-Term Assets	$89.51M	$101.8M
Total Long-Term Assets	$54.23M	$52.92M
Total Assets	$143.7M	$154.8M
YoY Change	-23.9%	0.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.785M	$10.75M
YoY Change	-16.6%	23.77%
Accrued Expenses	$13.17M	$12.46M
YoY Change	-10.58%	-12.85%
Deferred Revenue	$6.461M	$6.612M
YoY Change	-10.44%	-0.68%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$642.0K	$718.0K
YoY Change	-21.9%	18.09%
Total Short-Term Liabilities	$32.74M	$33.19M
YoY Change	-12.44%	-0.09%
LONG-TERM LIABILITIES
Long-Term Debt	$75.68M	$75.47M
YoY Change	18.93%	18.93%
Other Long-Term Liabilities	$40.00K	$12.73M
YoY Change	-99.73%	-14.38%
Total Long-Term Liabilities	$75.72M	$75.47M
YoY Change	19.0%	18.93%
TOTAL LIABILITIES
Total Short-Term Liabilities	$32.74M	$33.19M
Total Long-Term Liabilities	$75.72M	$75.47M
Total Liabilities	$121.5M	$122.0M
YoY Change	3.86%	8.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$266.7M	-$253.6M
YoY Change	29.25%	36.65%
Common Stock	$2.000K	$2.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$22.25M	$32.72M
YoY Change
Total Liabilities & Shareholders Equity	$143.7M	$154.8M
YoY Change	-23.9%	0.29%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$13.15M	-$23.48M
YoY Change	-36.79%	24.9%
Depreciation, Depletion And Amortization	$1.926M	$2.051M
YoY Change	4.28%	-3.3%
Cash From Operating Activities	-$11.04M	-$20.82M
YoY Change	-6.46%	5.4%
INVESTING ACTIVITIES
Capital Expenditures	$170.0K	$810.0K
YoY Change	-88.05%	0.75%
Acquisitions
YoY Change
Other Investing Activities	$9.224M	-$48.01M
YoY Change		-785.81%
Cash From Investing Activities	$9.054M	-$48.82M
YoY Change	-736.26%	-887.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.125M	-444.0K
YoY Change	-104.59%	5.97%
NET CHANGE
Cash From Operating Activities	-11.04M	-20.82M
Cash From Investing Activities	9.054M	-48.82M
Cash From Financing Activities	-2.125M	-444.0K
Net Change In Cash	-4.112M	-70.09M
YoY Change	-112.42%	401.29%
FREE CASH FLOW
Cash From Operating Activities	-$11.04M	-$20.82M
Capital Expenditures	$170.0K	$810.0K
Free Cash Flow	-$11.21M	-$21.63M
YoY Change	-15.24%	5.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2024Q1	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#OperatingExpenses
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49188170
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38326024
CY2023Q1	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#OperatingExpenses
CY2024Q1	akya	Standard Service Based Warranty Terms StandardServiceBasedWarrantyTerms	P1Y
CY2024Q1	akya	Extended Service Based Warranty Terms ExtendedServiceBasedWarrantyTerms	P1Y
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49340417
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49117738
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001711933
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49340417
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49117738
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-40344
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	Akoya Biosciences, Inc.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-5586242
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	100 Campus Drive
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	6th Floor
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Marlborough
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01752
CY2024Q1	dei	City Area Code CityAreaCode	855
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	896-8401
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.00001 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	AKYA
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49386247
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13039000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	83125000
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	48536000
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13473000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16994000
CY2024Q1	us-gaap	Inventory Net InventoryNet	22988000
CY2023Q4	us-gaap	Inventory Net InventoryNet	17877000
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	3793000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3794000
CY2024Q1	us-gaap	Assets Current AssetsCurrent	101829000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	121790000
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8964000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10729000
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	700000
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	699000
CY2024Q1	akya	Demo Inventory Net DemoInventoryNet	726000
CY2023Q4	akya	Demo Inventory Net DemoInventoryNet	893000
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	16699000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17412000
CY2024Q1	us-gaap	Goodwill Goodwill	18262000
CY2023Q4	us-gaap	Goodwill Goodwill	18262000
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5568000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8365000
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1348000
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1562000
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	654000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	657000
CY2024Q1	us-gaap	Assets Assets	154750000
CY2023Q4	us-gaap	Assets Assets	180369000
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	10747000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11776000
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12462000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13433000
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2654000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2681000
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	718000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	767000
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6612000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6688000
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	33193000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	35345000
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2928000
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	3193000
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	75469000
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	75254000
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	75000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	38000
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5713000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6238000
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	634000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	766000
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	4015000
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	5765000
CY2024Q1	us-gaap	Liabilities Liabilities	122027000
CY2023Q4	us-gaap	Liabilities Liabilities	126599000
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49340417
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49117738
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	2000
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2000
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	286292000
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	283839000
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-253555000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-230071000
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-16000
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	32723000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	53770000
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	154750000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	180369000
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18350000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21410000
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	9971000
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	9117000
CY2024Q1	us-gaap	Gross Profit GrossProfit	8379000
CY2023Q1	us-gaap	Gross Profit GrossProfit	12293000
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19863000
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	23124000
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5554000
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6378000
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	179000
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	227000
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2971000
CY2024Q1	us-gaap	Other Restructuring Costs OtherRestructuringCosts	1397000
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	29964000
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	29729000
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-21585000
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-17436000
CY2024Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2612000
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2054000
CY2024Q1	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	545000
CY2023Q1	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	5000
CY2024Q1	akya	Operating Lease Adjustment OperatingLeaseAdjustment	728000
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	937000
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	765000
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-161000
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-48000
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23421000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18773000
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63000
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-23484000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-18802000
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49188170
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38326024
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-23484000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-18802000
CY2024Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-16000
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	6000
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-16000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	6000
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-23500000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18796000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	53770000
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	36000
CY2024Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	149000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-23484000
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-16000
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2566000
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	32723000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	58581000
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	58000
CY2023Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	94000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-18802000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	6000
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2375000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	42124000
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-23484000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-18802000
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2051000
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2121000
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	215000
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	178000
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2566000
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2375000
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	37000
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	179000
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	227000
CY2024Q1	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	375000
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7310000
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	137000
CY2023Q1	akya	Operating Lease Adjustment OperatingLeaseAdjustment	598000
CY2024Q1	akya	Change In Inventory Reserve Adjustment ChangeInInventoryReserveAdjustment	2298000
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2971000
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3146000
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3214000
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4000
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2517000
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1029000
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1945000
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2133000
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3941000
CY2024Q1	akya	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-552000
CY2023Q1	akya	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-539000
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-341000
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	809000
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20824000
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19758000
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	810000
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	804000
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	48007000
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	7000000
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-48817000
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6196000
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	36000
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	58000
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	149000
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	94000
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	181000
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	148000
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	33000
CY2024Q1	akya	Refunds From Payments Of Deferred Offering Costs RefundsFromPaymentsOfDeferredOfferingCosts	-150000
CY2023Q1	akya	Refunds From Payments Of Deferred Offering Costs RefundsFromPaymentsOfDeferredOfferingCosts	-202000
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-444000
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-419000
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-70085000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13981000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	83824000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	74532000
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13739000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60551000
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	2243000
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1793000
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	84000
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	529000
CY2024Q1	akya	Number Of Geographic Regions For Sales NumberOfGeographicRegionsForSales	3
CY2024Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	61575000
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-253555000
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20824000
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18350000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21410000
CY2024Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2196000
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1276000
CY2024Q1	us-gaap	Revenue Practical Expedient Incremental Cost Of Obtaining Contract RevenuePracticalExpedientIncrementalCostOfObtainingContract	true
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1	P4Y
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	420000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45000
CY2024Q1	akya	Cash Cash Equivalents And Marketable Securities Cost Basis CashCashEquivalentsAndMarketableSecuritiesCostBasis	60080000
CY2024Q1	akya	Cash Cash Equivalents And Marketable Securities Gross Unrealized Losses CashCashEquivalentsAndMarketableSecuritiesGrossUnrealizedLosses	16000
CY2024Q1	akya	Cash Cash Equivalents And Marketable Securities Fair Value Disclosure CashCashEquivalentsAndMarketableSecuritiesFairValueDisclosure	60064000
CY2023Q4	akya	Cash Cash Equivalents And Marketable Securities Cost Basis CashCashEquivalentsAndMarketableSecuritiesCostBasis	76844000
CY2023Q4	akya	Cash Cash Equivalents And Marketable Securities Fair Value Disclosure CashCashEquivalentsAndMarketableSecuritiesFairValueDisclosure	76844000
CY2024Q1	akya	Number Of Debt Securities Held NumberOfDebtSecuritiesHeld	10
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18099000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20392000
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9135000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9663000
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8964000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10729000
CY2024Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	902000
CY2023Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2024Q1	akya	Demo Inventory Estimated Useful Life DemoInventoryEstimatedUsefulLife	P3Y
CY2023	akya	Demo Inventory Estimated Useful Life DemoInventoryEstimatedUsefulLife	P3Y
CY2024Q1	akya	Demo Inventory Gross DemoInventoryGross	4164000
CY2023Q4	akya	Demo Inventory Gross DemoInventoryGross	4284000
CY2024Q1	akya	Accumulated Depreciation Depletion And Amortization Demo Inventory AccumulatedDepreciationDepletionAndAmortizationDemoInventory	3438000
CY2023Q4	akya	Accumulated Depreciation Depletion And Amortization Demo Inventory AccumulatedDepreciationDepletionAndAmortizationDemoInventory	3391000
CY2024Q1	akya	Demo Inventory Net DemoInventoryNet	726000
CY2023Q4	akya	Demo Inventory Net DemoInventoryNet	893000
CY2024Q1	akya	Depreciation Demo Inventory DepreciationDemoInventory	252000
CY2023Q1	akya	Depreciation Demo Inventory DepreciationDemoInventory	326000
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	13473000
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	420000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	45000
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	375000
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	420000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	29990000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13291000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16699000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	29990000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12578000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17412000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2141000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2853000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2823000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1955000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1762000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	5165000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16699000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4112000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7074000
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3839000
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1911000
CY2024Q1	akya	Accrued Inventory Purchases AccruedInventoryPurchases	458000
CY2023Q4	akya	Accrued Inventory Purchases AccruedInventoryPurchases	609000
CY2024Q1	akya	Customer Deposit Liability Current CustomerDepositLiabilityCurrent	1479000
CY2023Q4	akya	Customer Deposit Liability Current CustomerDepositLiabilityCurrent	1096000
CY2024Q1	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	791000
CY2023Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	711000
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1783000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2032000
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12462000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13433000
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	419000
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	448000
CY2024Q1	akya	Debt Instrument Accretion Of Fee DebtInstrumentAccretionOfFee	888000
CY2023Q4	akya	Debt Instrument Accretion Of Fee DebtInstrumentAccretionOfFee	702000
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	75469000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	75254000
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2024Q1	akya	Common Stock Voting Rights Per Share CommonStockVotingRightsPerShare	1
CY2023	akya	Common Stock Voting Rights Per Share CommonStockVotingRightsPerShare	1
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49340417
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49117738
CY2024Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	11157498
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	8924291
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63000
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29000
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-23484000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-18802000
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49188170
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38326024
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8325824
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8293368
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18350000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21410000
CY2024Q1	akya	Number Of Countries With Concentration Risk NumberOfCountriesWithConcentrationRisk	0
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2971000
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2024Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	34000
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	20000
CY2024Q1	us-gaap	Lease Cost LeaseCost	982000
CY2023Q1	us-gaap	Lease Cost LeaseCost	1033000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2136000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2839000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2636000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1104000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	436000
CY2024Q1	akya	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	562000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9713000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1346000
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	8367000
CY2024Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	581000
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	444000
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	239000
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	239000
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	60000
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1563000
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	211000
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	1352000
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y7M6D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y4M24D
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M6D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0785
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0785
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0990
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0683
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	718000
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	753000
CY2024Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	34000
CY2023Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	20000
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	181000
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	148000
CY2024Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	51
CY2024Q1	us-gaap	Restructuring Charges RestructuringCharges	1257000
CY2024Q1	akya	Employee And Equipment Relocation Costs EmployeeAndEquipmentRelocationCosts	140000
CY2024Q1	akya	Accrued Liabilities Restructuring Charges AccruedLiabilitiesRestructuringCharges	89000
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001558370-24-007998-index-headers.html	Edgar Link	pending
0001558370-24-007998-index.html	Edgar Link	pending
0001558370-24-007998.txt	Edgar Link	pending
0001558370-24-007998-xbrl.zip	Edgar Link	pending
akya-20240331.xsd	Edgar Link	pending
akya-20240331x10q.htm	Edgar Link	pending
akya-20240331xex31d1.htm	Edgar Link	pending
akya-20240331xex31d2.htm	Edgar Link	pending
akya-20240331xex32d1.htm	Edgar Link	pending
akya-20240331xex32d2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
akya-20240331_def.xml	Edgar Link	unprocessable
akya-20240331_lab.xml	Edgar Link	unprocessable
akya-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
akya-20240331x10q_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
akya-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AKYA
Akoya Biosciences, Inc. Stock $akya

2024 Q2 Form 10-Q Financial Statement

#000155837024007998 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AKYA Akoya Biosciences, Inc. Stock $akya

2024 Q2 Form 10-Q Financial Statement

#000155837024007998 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AKYA
Akoya Biosciences, Inc. Stock $akya